A Paradoxical Case of Phospholipase A2 Receptor Antibody Seropositivity with NELL-1 Membranous Nephropathy (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0686; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "(Fig-1) She received rituximab 1000 mg, diuresis, and angiotensin receptor blockade...The significance of circulating anti-PLA2R ab in our case is unknown. Our case highlights the current limitations of serum antibody testing for MN and the continued need for a kidney biopsy for its diagnosis and classification."
Clinical • Acute Kidney Injury • Cardiovascular • Glomerulonephritis • Myeloproliferative Neoplasm • Nephrology • Pulmonary Disease • Pulmonary Embolism • Renal Disease • Septic Shock • Thrombocytosis • Thrombosis • EGF • NELL1
|
|
Aditi Singh; Ziad Alahmadi; Reid C. Wilkins; Abbal Koirala
|